ChartMill assigns a Buy % Consensus number of 48% to AADI. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-27 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-08-21 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-08-21 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-12-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-12-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-29 | HC Wainwright & Co. | Maintains | Buy |
| 2022-04-11 | HC Wainwright & Co. | Maintains | Buy |
| 2022-01-11 | Jefferies | Initiate | Buy |
| 2021-11-24 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-01 | Cowen & Co. | Initiate | Outperform |
| 2021-09-14 | Ladenburg Thalmann | Initiate | Buy |
| 2021-09-08 | Piper Sandler | Initiate | Overweight |
| 2021-08-30 | HC Wainwright & Co. | Maintains | Buy |
8 analysts have analysed AADI and the average price target is 3.06 USD. This implies a price increase of 49.27% is expected in the next year compared to the current price of 2.05.
The consensus rating for AADI BIOSCIENCE INC (AADI) is 47.5 / 100 . This indicates that analysts generally have a neutral outlook on the stock.